Fluoxetine: all 159 studies that test it

Page 1 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• TDM-Guided Treatment With SSRIs in Hospitalized Adults and ChildrenRecruitingNCT07478796Phase 4
• Fluoxetine and Understanding Social ExperiencesNot yet recruitingNCT07456501Not applicable
• Fluoxetine on Emotional Experience (FLEX) StudyRecruitingNCT07424781Not applicable
• SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and AnxietyRecruitingNCT07174947Phase 2
• Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in NigeriaNot yet recruitingNCT07110831Phase 4
• Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionRecruitingNCT06898606Phase 1/2
• Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder FeaturesNot yet recruitingNCT06506136Phase 2
• The Friendship Bench Plus TrialRecruitingNCT06384209Not applicable
• Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal CancerRecruitingNCT06225011Phase 1
• Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?RecruitingNCT06046859Phase 4
• Identifying and Treating Depression in the Orthopaedic Trauma PopulationRecruitingNCT05976347Phase 4
• Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)RecruitingNCT05814640Phase 1/2
• Rapid Improvement of Depression of Fluoxetine Combined With ATPRecruitingNCT05431413Phase 2
• Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingNCT05041907Phase 2
• Study of Dextromethorphan in OCD and Related DisordersRecruitingNCT04899687Phase 2
• The Effects of Fluoxetine and/or DHEARecruitingNCT03228732Early Phase 1
• The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromeRecruitingNCT00768820Phase 4
• Study of Neuro-Cognitive Correlates of Pediatric Anxiety DisordersRecruitingNCT00018057Phase 2
• Fluoxetine Treatment of Depression in Down SyndromeCompletedNCT05458479Phase 4Results posted
• Fluoxetine Mitigation Mental Health Study for Patients With Musculoskeletal TraumaCompletedNCT04850222Phase 2Results posted
• Fluoxetine to Reduce Intubation and Death After COVID19 InfectionCompletedNCT04377308Phase 4Results posted
• Poststroke Depression in Hemorrhagic StrokeCompletedNCT03826875Phase 2Results posted
• Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in TanzaniaCompletedNCT03728153Phase 2Results posted
• Fluoxetine in Pulmonary Arterial Hypertension (PAH) TrialCompletedNCT03638908Phase 2Results posted
• SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research ProjectCompletedNCT03466346Not applicableResults posted
• Identifying and Treating Depression in Hemodialysis PatientsCompletedNCT03390933Phase 4Results posted
• Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRICompletedNCT02929667Phase 2Results posted
• Fluoxetine for Visual Recovery After Ischemic StrokeTerminatedNCT02737930Phase 2Results posted
• A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and ComorbidityCompletedNCT02655354Not applicableResults posted
• Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET ImagingCompletedNCT02473250Phase 4Results posted
• 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar DepressionTerminatedNCT02389712Phase 4Results posted
• Fluoxetine vs Aripiprazole Comparative Trial (FACT)TerminatedNCT02357849Phase 4Results posted
• Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke PatientsCompletedNCT02208466Phase 2Results posted
• An Adaptive Treatment Strategy for Adolescent Depression-ContinuationCompletedNCT02017535Phase 1/2Results posted
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term DosingCompletedNCT01808651Phase 3Results posted
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term DosingCompletedNCT01808612Phase 3Results posted
• An Adaptive Treatment Strategy for Adolescent DepressionCompletedNCT01802437Phase 1/2Results posted
• Characterization and Sequential Pharmacotherapy of Severe Mood DysregulationCompletedNCT01714310Phase 2Results posted
• Homeopathic Treatment for Depression in Peri- and Postmenopausal WomenCompletedNCT01635218Phase 2Results posted
• A Study of LY110140 in Healthy Japanese Male ParticipantsCompletedNCT01569126Phase 1Results posted
• Repeated Partial Sleep Deprivation to Augment SSRI Response in DepressionCompletedNCT01545843Phase 2Results posted
• 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting ConditionsCompletedNCT01247285Phase 1Results posted
• 90 mg Fluoxetine Hydrochloride Capsules Under Fasting ConditionsCompletedNCT01247272Phase 1Results posted
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
• Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial EpilepsyCompletedNCT00986310Not applicableResults posted
• Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)CompletedNCT00965562Not applicableResults posted
• Prevention of Relapse & Recurrence of Bipolar DepressionCompletedNCT00961961Phase 4Results posted
• Safety and Efficacy of Fluoxetine in Pulmonary Arterial HypertensionCompletedNCT00942708Phase 2Results posted
• Brain Imaging Techniques That Predict Antidepressant ResponsivenessCompletedNCT00909155Not applicableResults posted
• Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality DisorderCompletedNCT00834834Phase 4Results posted
• The Role of GABA and Neurosteroids in Premenstrual Dysphoric DisorderCompletedNCT00678574Phase 4Results posted
• Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in WomenCompletedNCT00676026Not applicableResults posted
• Effect of Antidepressants on Sex Hormone Levels and Sexual FunctioningCompletedNCT00611975Phase 4Results posted
• PET Imaging Study of Recovered AnorexicsCompletedNCT00603018Not applicableResults posted
• Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar DisorderTerminatedNCT00592852Phase 4Results posted
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive SymptomsCompletedNCT00578669Phase 3Results posted
• Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality DisorderCompletedNCT00533117Phase 4Results posted
• Early Detection and Intervention for the Prevention of PsychosisCompletedNCT00531518Not applicableResults posted
• Fluoxetine and Bupropion to Treat Patients With Depression and AlcoholismTerminatedNCT00449007Phase 4Results posted
• Treatment of Hypochondriasis With CBT and/or SSRICompletedNCT00339079Phase 1/2Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00296725Phase 1/2Results posted
• Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia NervosaCompletedNCT00288574Phase 4Results posted
• Fluoxetine in Pediatric Body Dysmorphic DisorderCompletedNCT00245635Phase 4Results posted
• Early Intervention With Fluoxetine in AutismCompletedNCT00183339Phase 2Results posted
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana DependenceCompletedNCT00149643Phase 2Results posted
• Safety and Efficacy of Fluoxetine in Juvenile FibromyalgiaCompletedNCT00115804Phase 3Results posted
• A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive DisorderCompletedNCT00078754Phase 2Results posted
• Pharmacological Intervention Project (Fluoxetine)CompletedNCT00027378Phase 2Results posted
• Fluoxetine in Refractory Superior Mesenteric Artery Syndrome by Targeting Comorbid Somatic Symptom DisorderCompletedNCT07115472Not applicable
• Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIVWithdrawnNCT07007221Phase 2
• Fluoxetine for Refractory ConstipationCompletedNCT06750445Not applicable
• Fluoxetine in KCNC1-related DisorderCompletedNCT06341127Not applicable
• Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.Status unknownNCT06185361Not applicable
• Improving Outcomes in Depression in Primary Care in a Low Resource SettingActive, not recruitingNCT05944926Phase 3
• Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)Active, not recruitingNCT05634707Early Phase 1
• Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting ConditionCompletedNCT05532332Phase 1
• Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With FluoxetineCompletedNCT05378711Phase 2
• Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New GuineaWithdrawnNCT05283954Phase 2/3
• Fluoxetine vs CBT in Childhood Anxiety DisordersActive, not recruitingNCT04760275Phase 3
• The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in ChildrenStatus unknownNCT04676139Phase 3
• Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)WithdrawnNCT04570449Early Phase 1
• Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine TreatmentStatus unknownNCT04154813Not applicable
• The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled StudyCompletedNCT03455088Not applicable
• Fluoxetine Opens Window to Improve Motor Recovery After StrokeCompletedNCT03448159Phase 2
• OxSYPan: Oxford Study With Young People on AntidepressantsCompletedNCT03436173Not applicable
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsStatus unknownNCT03219008Phase 4
• Measurement-based Care for Depression in Resource-Poor SettingsCompletedNCT02916238Phase 4
• Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic StrokeCompletedNCT02767999Phase 4
• The Staged Treatment in Early Psychosis StudyCompletedNCT02751632Phase 3
• Hierarchical Treatment Based on Somatization Symptom ChecklistStatus unknownNCT02723903Phase 1/2
• Efficacy of Fluoxetine - a Trial in StrokeCompletedNCT02683213Phase 3
• Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaCompletedNCT02593734Phase 4
• Efficacy of Fluoxetine Against Seizure-induced Central ApneasCompletedNCT02569970Phase 3
• Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?Status unknownNCT02562053Phase 3
• Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual SyndromeStatus unknownNCT02488538Phase 3
• Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual SyndromeStatus unknownNCT02427334Phase 3
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke"TerminatedNCT02063425Not applicable
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsCompletedNCT02022709Phase 4
• A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy SubjectsCompletedNCT01967979Phase 1

← Fluoxetine overview